Redmile Group’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,586,174
| Closed | -$4.12M | – | 38 |
|
|
2025
Q4 | $4.12M | Hold |
1,586,174
| – | – | 0.3% | 30 |
|
|
2025
Q3 | $2.79M | Hold |
1,586,174
| – | – | 0.27% | 34 |
|
|
2025
Q2 | $2.2M | Sell |
1,586,174
-298,215
| -16% | -$389K | 0.23% | 41 |
|
|
2025
Q1 | $1.86M | Sell |
1,884,389
-31,700
| -2% | -$38.2K | 0.18% | 50 |
|
|
2024
Q4 | $2.51M | Sell |
1,916,089
-26,466
| -1% | -$78.8K | 0.17% | 51 |
|
|
2024
Q3 | $6.68M | Hold |
1,942,555
| – | – | 0.39% | 44 |
|
|
2024
Q2 | $6.41M | Sell |
1,942,555
-73,747
| -4% | -$263K | 0.39% | 45 |
|
|
2024
Q1 | $9.5M | Sell |
2,016,302
-132,446
| -6% | -$849K | 0.35% | 60 |
|
|
2023
Q4 | $15.7M | Sell |
2,148,748
-255,947
| -11% | -$1.43M | 0.56% | 45 |
|
|
2023
Q3 | $29M | Sell |
2,404,695
-23,640
| -1% | -$244K | 1.38% | 23 |
|
|
2023
Q2 | $25.7M | Sell |
2,428,335
-104,715
| -4% | -$1.08M | 0.99% | 31 |
|
|
2023
Q1 | $24.9M | Sell |
2,533,050
-151,346
| -6% | -$1.74M | 1.08% | 36 |
|
|
2022
Q4 | $39.5M | Hold |
2,684,396
| – | – | 1.62% | 22 |
|
|
2022
Q3 | $32.6M | Sell |
2,684,396
-36,600
| -1% | -$471K | 1.26% | 25 |
|
|
2022
Q2 | $38.1M | Sell |
2,720,996
-12,000
| -0.4% | -$141K | 1.45% | 24 |
|
|
2022
Q1 | $38.9M | Sell |
2,732,996
-56,500
| -2% | -$838K | 1.21% | 25 |
|
|
2021
Q4 | $58.8M | Buy |
2,789,496
+221,800
| +9% | +$5.22M | 1.34% | 21 |
|
|
2021
Q3 | $67.4M | Sell |
2,567,696
-56,700
| -2% | -$1.83M | 1.18% | 27 |
|
|
2021
Q2 | $81.8M | Sell |
2,624,396
-41,100
| -2% | -$1.35M | 1.21% | 29 |
|
|
2021
Q1 | $81.8M | Buy |
2,665,496
+17,800
| +0.7% | +$605K | 1.15% | 28 |
|
|
2020
Q4 | $90.8M | Buy |
2,647,696
+242,722
| +10% | +$7.25M | 1.1% | 29 |
|
|
2020
Q3 | $74M | Buy |
2,404,974
+18,800
| +0.8% | +$498K | 1.36% | 25 |
|
|
2020
Q2 | $74M | Buy |
+2,386,174
| New | +$76.6M | 1.37% | 22 |
|
Redmile Group's RPTX Position: Q1 2026 in Review
Redmile Group sold out of Repare Therapeutics (RPTX) in Q1 2026, closing a stake of 1,586,174 shares — an estimated $4.12M sold.
Redmile Group first reported a position in RPTX in Q2 2020 and held it in 23 quarters. The position peaked at $90.8M in Q4 2020. 0 funds tracked by Wall St. Rank hold RPTX as of Q1 2026.
- Redmile Group reported no remaining Repare Therapeutics position as of Q1 2026 after selling out during the quarter.
- Redmile Group sold 1,586,174 Repare Therapeutics shares in Q1 2026, an estimated $4.12M.
- Redmile Group first reported a position in Repare Therapeutics in Q2 2020 and held it in 23 quarters.
- Redmile Group's Repare Therapeutics position peaked at $90.8M in Q4 2020.
- 0 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2026.
Based on Redmile Group's 13F filing for Q1 2026, filed 15 May 2026.